Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-700
Closed -$218K 7128
2025
Q1
$218K Buy
+700
New +$207K ﹤0.01% 4645
2024
Q2
Sell
-6,600
Closed -$1.88M 6887
2024
Q1
$1.88M Buy
6,600
+6,000
+1,000% +$1.76M ﹤0.01% 3022
2023
Q4
$173K Hold
600
﹤0.01% 4553
2023
Q3
$161K Hold
600
﹤0.01% 4497
2023
Q2
$133K Sell
600
-5,500
-90% -$1.28M ﹤0.01% 4841
2023
Q1
$1.47M Buy
6,100
+2,000
+49% +$491K ﹤0.01% 3117
2022
Q4
$1.08M Buy
+4,100
New +$1.1M ﹤0.01% 3199
2022
Q1
Sell
-46,100
Closed -$10.4M 6996
2021
Q4
$10.4M Buy
+46,100
New +$9.73M ﹤0.01% 1849
2021
Q2
Sell
-7,500
Closed -$1.87M 6864
2021
Q1
$1.87M Buy
+7,500
New +$1.79M ﹤0.01% 3757
2020
Q1
Sell
-40,000
Closed -$112K 6154
2019
Q4
$112K Buy
+40,000
New +$8.82M ﹤0.01% 5236
2019
Q3
Sell
-3,000
Closed -$41K 6349
2019
Q2
$41K Buy
+3,000
New +$537K ﹤0.01% 5604
2017
Q2
Sell
-133,900
Closed -$386K 6200
2017
Q1
$386K Buy
+133,900
New +$22.2M ﹤0.01% 4418
2016
Q4
Sell
-20,000
Closed -$316K 6239
2016
Q3
$316K Hold
20,000
﹤0.01% 4214
2016
Q2
$183K Buy
+20,000
New +$3.11M ﹤0.01% 4456
2016
Q1
Sell
-16,000
Closed -$17K 6171
2015
Q4
$17K Buy
+16,000
New +$2.51M ﹤0.01% 5616
2015
Q3
Sell
-10,000
Closed -$1K 6170
2015
Q2
$1K Buy
+10,000
New +$1.6M ﹤0.01% 6212
2015
Q1
Sell
-2,700
Closed -$10K 6147
2014
Q4
$10K Hold
2,700
﹤0.01% 5616
2014
Q3
$3K Buy
+2,700
New +$353K ﹤0.01% 5912

Other funds holding AMGN

Wells Fargo's AMGN Position: Q1 2026 in Review

Wells Fargo reduced its Amgen (AMGN) stake by 0.32% in Q1 2026, selling an estimated $8.09M and leaving 7,088,010 shares worth $2.49B. The position accounts for 0.47% of the portfolio, ranked #34.

Wells Fargo first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wells Fargo held 7,088,010 shares of Amgen worth $2.49B as of Q1 2026.
  • Wells Fargo sold 22,683 Amgen shares in Q1 2026, an estimated $8.09M.
  • Amgen made up 0.47% of Wells Fargo's portfolio in Q1 2026, its #34 holding.
  • Wells Fargo first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.